Switch View
© ACCESSWIRE
05.09.2025
ISIN: US03476V1008
Angle plc
ANPCY
LISTED
OTC
Angle PLC Announces Notice of Results
News Preview
ANGLE plc ("the Company") Notice of Interim Results and Webcast GUILDFORD, SURREY / ACCESS Newswire / September 5, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, will be releasing...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
News Preview
LOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor meetings at Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference on Thursday, September 11, 2025....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils AI Age-Based Health Risk Estimator Targeting $1 Trillion Digital Health Market by 2030
News Preview
MESA, ARIZONA / ACCESS Newswire / September 5, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today unveiled its AI Facial Age-Based Health Risk Estimator, a breakthrough technology that uses facial imaging to deliver predictive health insights.The system leverages micro-wrinkle density, skin elasticity, and tonal gradient analysis to genera...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
05.09.2025
ISIN: US0352551081
Anika Therapeutics Inc
ANIK
LISTED
NASDAQ
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BEDFORD, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September 2, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,5...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ACCESSWIRE
05.09.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts
News Preview
Click here to register SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / September 5, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference, which takes place September 8-10, 2025.Participation Instruction...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: CA68237C1059
Onco-Innovations Limited
ONCO
LISTED
CSE
Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
News Preview
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. John Mackey, Professor Emeritus in the Department of Oncology at the University of Alberta, to its Scientific and Clinical Advisory Board...
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby’s live vital signs and receive real-time health notifications, deliv...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: US9495031067
Wellgistics Health, Inc.
WGRX
LISTED
NASDAQ
Wellgistics Health, Inc. to Present at September Investor Conferences
News Preview
TAMPA, FL / ACCESS Newswire / September 5, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that Brian Norton, Chief Executive Officer, together with members...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
News Preview
LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics market, today announced that the Company's proven Thermage technology has successfully been used to perform more than 5 million skin tightening...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: SE0006219176
Arcoma AB
ARCOMA
LISTED
STO
Arcoma AB inför incitamentsprogram kopplat till aktieköp för ledning och andra ledande befattningshavare i företaget.
News Preview
PRESSRELEASE...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
News Preview
COPENHAGEN, Denmark, September 5, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 3,818,710 as a consequence of employees’ exercise of warrants....
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2025
ISIN: CH1330780979
Curatis Holding AG
CURN
LISTED
SIX
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
News Preview
Curatis Holding AG
/ Key word(s): Agreement/Incoming Orders
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
05.09.2025 / 07:00 CET/CEST
MEDIA RELEASE
Liestal, Switzerland, 5 September 2025: Curatis Holding AG (SIX: CURN, 'Curatis') announces a new distribution contrac......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
05.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
News Preview
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia
at the 2025 World Congress of Biological Psychiatry (WCBP)
The importance of glutamate release modulation by evenamide used as an add-on therapy for patients with schizophrenia inadequately responding to their second-generati......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron präsentiert Daten und Updates zu seinem klinischen Programm zur Entwicklung von Evenamide als Zusatztherapie bei Schizophrenie auf dem Weltkongress für Biologische Psychiatrie (WCBP) 2025
News Preview
Newron präsentiert Daten und Updates zu seinem klinischen Programm zur Entwicklung von Evenamide als Zusatztherapie bei Schizophrenie auf dem Weltkongress für Biologische Psychiatrie (WCBP) 2025
Die Bedeutung der Modulation der Glutamat-Freisetzung durch Evenamide als Zusatztherapie für Patienten mit Schizophrenie, die unzureichend auf Antipsychot......
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: CH1330780979
Curatis Holding AG
CURN
LISTED
SIX
Curatis Expands Distribution Business With Phoenix Labs with up to CHF 5m Additional Annual Revenues
News Preview
Curatis Holding AG (SIX: CURN, 'Curatis') announces a new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland.
Significant revenue growth with new products
Curatis has signed a contract with Phoenix Labs (Ireland) to distribute four products in the areas of pain management and urology in Switzerland, starting fro...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk to present new semaglutide data on ‘food noise’, body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress
News Preview
Bagsværd, Denmark, 5 September 2025 – Novo Nordisk today announced the presentation of 35 abstracts from across its diabetes and obesity portfolio at the upcoming European Association for the Study of Diabetes (EASD) congress 2025 from 15 to 19 September in Vienna, Austria. The presentations include clinical and real-world data reinforcing semaglut...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia to collaborate with two leading academic medical centers to launch IMPACT-HTN – a US initiative to transform care for patients with difficult-to-control hypertension
News Preview
Allschwil, Switzerland & Radnor, Philadelphia – September 5, 2025Idorsia Ltd (SIX: IDIA) announces a first-of-its-kind initiative with the Stanford Hypertension Center and Duke Heart Center to launch IMPACT-HTN, a new three-phase program to transform and modernize the management of difficult-to-control hypertension. Patients requiring multiple...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
New data for Roche's Vabysmo reinforce its efficacy, safety and durability in neovascular or “wet” age-related macular degeneration (nAMD)
News Preview
Basel, 05 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new data from the AVONELLE-X and SALWEEN studies of Vabysmo® (faricimab),1,2 presented at the 25th Euretina Congress in Paris, France. Data from the open-label AVONELLE-X study reinforce the efficacy, safety and durability of Vabysmo over four years in neovascular or “wet...
Themefolio
Profiler
Peergroup
© Newsfile
05.09.2025
ISIN: CA12675Q1019
C21 Investments Inc.
CXXI
LISTED
CSE
C21 Investments Announces Settlement of Eco Firma Farms Litigation
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced it has entered into a settlement agreement (the "Settlement Agreement") with respect to certain actions filed in the Oregon State Circuit Court for Cl...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: CA0909741062
BioNxt Solutions Inc.
BNXT
LISTED
CSE
BioNxt Solutions Completes Up-Listing to The OTCQB Market
News Preview
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT), is pleased to announce that the common shares of the Company (the "Common Shares") shall commence trading on the OTCQB market under the ticker symbol "BNXTF" as of Septembe...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
News Preview
NUTX Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, Sept. 4, 2025 /PRNewswire/ -- A new class-action lawsuit alleges that Nutex Health, Inc. (NASDAQ: NUTX), a hospital and healthcare services company, engaged in a fraudulent scheme with a third-party billing firm to inflate its revenues, leading to millions of dollars in...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. LON...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA10919W4056
Bright Minds Biosciences Inc.
DRUG
LISTED
NASDAQ
BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING
News Preview
VANCOUVER, BC, Sept. 4, 2025 /CNW/ - Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") announces that it has entered into an equity distribution agreement (the "Equity Distribution Agreement") providing for an at-the-market equity offering program ("ATM") with Piper Sandler & Co. and Cantor Fitzgerald...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: KYG4672N1198
HUTCHMED (China) Ltd
13
LISTED
HKSE
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the 2025 World Conference on Lung Cancer (“WCLC”) taking place on September 6-9,...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that on September 2, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 25,750 shares of Puma common stock to four new non-executive employees.
The awards were granted under Puma’s 2017...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Sept. 2, 2025, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock opt...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
News Preview
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology published a study highlighting the performance of Myriad’s molecular residual disease (MRD) test, Precise® MRD, in patients with oligometastatic clear-cell r...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulti...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Phreesia Announces Second Quarter Fiscal 2026 Results
News Preview
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025.
“I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net incom...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference
News Preview
WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and Ankle Society Annual Conference in Savannah, Ga. From September 10-13, 2025, Zimmer Biomet's wholly owned subsidiary, Paragon 28, will feature a sui...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions
News Preview
Phreesia, Inc. (NYSE: PHR) (“Phreesia”), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with its subsidiaries, “AccessOne”), a portfolio company of Frontier Growth, for aggregate consideration of $160 million in cash (the “AccessOne Acquisition...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
News Preview
THOUSAND OAKS, Calif., Sept. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 9:15 a.m. ET on September 9, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and Kave Niksefat, senior vice president of Global Marketing and Access at Amgen,...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: CA68405U1012
Optimind Pharma Corp.
OMND
LISTED
CSE
Optimind Pharma Announces Termination of Letter of Intent
News Preview
Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that its previously announced non-binding letter of intent dated March 18, 2025 with Monjin Interviews Private Limited ("Monjin"), with respect to the Company's acquisition of Monjin, has been mutually terminated by...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: CA74141E1043
PreveCeutical Medical Inc.
PREV
LISTED
CSE
PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") dated September 3, 2025 with its subsidiary, BioGene Therapeutics Inc. ("BioGe...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
News Preview
NEW HOPE, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced new data from its AVIM therapy program, presented at the HRX Live 2025 Meeting, in A...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief (PEPFAR) to deliver lenacapavir—Gilead's twice-yearly injectable HIV-1 capsid inhibitor—for the prevention of HIV as pre-exposure prophylaxis (PrEP). This is a key component of Gilead’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US86889P2083
Surrozen, Inc.
SRZN
LISTED
NASDAQ
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 at 3:20 p.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US5147661046
Lifecore Biomedical Inc
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
News Preview
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual Contract Pharma Contracting and Outsourcing Conference. Recognized as one of the top annual e...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on September 1, 2025 to 17 new non-executive employees as equity inducem...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
News Preview
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
News Preview
BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of risperidone extended-release injectable suspension 12.5 mg/vial, 25 mg/vial, 37.5 mg/vial and 50 mg/vial, which references Janssen’s Risperdal Consta®. The product i...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US6031701013
Mineralys Therapeutics Inc
MLYS
LISTED
NASDAQ
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
News Preview
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announce...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US45339J1051
Indaptus Therapeutics, Inc.
INDP
LISTED
NASDAQ
Indaptus Therapeutics Provides Clinical Update
News Preview
Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US74006W1080
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
Praxis Precision Medicines to Participate in September Investor Conferences
News Preview
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that Praxis’ management w...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: CA98402E2069
Xebra Brands
XBRA
LISTED
CSE
CSE Bulletin: Suspension - XEBRA Brands Ltd. (XBRA)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 4 septembre/September 2025) - Effective immediately, XEBRA Brands Ltd. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the British Columbia Securities Commission....
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Replimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of REPL during the...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US1255231003
Cigna Group (The)
CI
LISTED
NYSE
AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group
News Preview
AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of “bbb+” (Good) to The Cigna Group’s (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] new senior unsecured notes. In addition, AM Best has assigned indicative Long-Term IRs on the recently filed shelf registration of Cigna. The outlook assigned to these Credit Ratings (ratin...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
News Preview
The DJS Law Group reminds investors of a class action lawsuit against RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of RXST during the class per...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NEOG
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Neogen Corporation (“Neogen” or “the Company”) (NASDAQ: NEOG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of NEOG during the c...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
News Preview
First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting
GALWAY, Ireland and NASHVILLE, Tenn., Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performa...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Deadline Approaching: Semler Scientific Inc. (SMLR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming October 28, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INV...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Deadline Approaching: LifeMD, Inc. (LFMD) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR WHO SUF...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Semler Scientific, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler Scientific" or "the Company") (NASDAQ: SMLR) and certain of its officers....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation (NEOG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
Shareholders with losses of $100,000 or more are encouraged to contact the firm.
BENSALEM, Pa., Sept. 4, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG)....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Berger Montague PC Investigates Securities Claims Against LifeMD, Inc. (NASDAQ: LFMD)
News Preview
PHILADELPHIA, Sept. 4, 2025 /PRNewswire/ -- Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period")....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US14149Y1082
Cardinal Health Inc
CAH
LISTED
NYSE
Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site
News Preview
DUBLIN, Ohio, Sept. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced the opening of its newest distribution center in Fort Worth, Texas – a facility solely dedicated to the at-Home Solutions business, a leading medical supplies provider that serves more than 6 million people annually in the United States. In addition, Cardinal Health...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that JAMA has published full results from the Company’s positive Phase 2b study of MM120 (lysergide D-tartrate, LSD) in 198 adults with moder...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US30161Q1040
Exelixis Inc
EXEL
LISTED
NASDAQ
EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or "the Company") (NASDAQ: EXEL) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that the ClearPoint Prism® Neuro Laser Therapy System ("ClearPoint Prism") receiv...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
